Immix Biopharma Inc.
IMMX | NASDAQ
$7.20
-$0.77 (-9.66%)
At close: Nov 4, 2026, 4:00 PM ET
$7.27
+$0.07 (+0.97%)
After-hours:
Nov 5, 2026, 4:27 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -12.46M | -10.8M | -10.89M | -7.66M | -6.72M | -4.68M | -4.99M | -7.39M | -4.7M | -5.59M | -5.38M | -4.52M | -3.72M | -2.52M | -3.79M | -1.53M | -1.56M | -1.33M | -598.34K | -347.99K | -243.17K | -162.52K |
Interest Income | 913.66K | 717.17K | 216.71K | 84.54K | 104.06K | 150.22K | 185.85K | 256.68K | 306.92K | 267.91K | 228.58K | 186.69K | 128.85K | 27.89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -11.54M | -10.09M | -10.68M | -7.58M | -6.61M | -4.53M | -4.8M | -7.14M | -4.4M | -5.32M | -5.15M | -4.34M | -3.59M | -2.49M | -3.79M | -1.53M | -1.56M | -1.33M | -22.75M | -401.93K | -207.03K | -1.02M |
Net Income | -11.56M | -10.09M | -10.69M | -7.59M | -6.62M | -4.54M | -4.81M | -7.15M | -4.39M | -5.26M | -5.09M | -4.28M | -3.58M | -2.48M | -3.8M | -1.54M | -1.56M | -1.33M | -22.76M | -403.27K | -208.64K | -1.02M |
Selling & General & Admin | 7.12M | 4.82M | 5.17M | 3.08M | 2.75M | 2.71M | 3.61M | 2.95M | 2.48M | 2.34M | 2.28M | 2.42M | 1.51M | 1.2M | 1.53M | 837.44K | 953.2K | 700.51K | 589.1K | 318.3K | 180.4K | 137.68K |
Research & Development | 5.33M | 5.98M | 5.73M | 4.58M | 3.97M | 1.98M | 1.37M | 4.45M | 2.22M | 3.25M | 3.1M | 2.11M | 2.21M | 1.32M | 2.26M | 695.94K | 607.75K | 629.53K | 9.24K | 29.69K | 62.76K | 24.84K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 12.46M | 10.8M | 10.89M | 7.66M | 6.72M | 4.68M | 4.99M | 7.39M | 4.7M | 5.59M | 5.38M | 4.52M | 3.72M | 2.52M | 3.79M | 1.53M | 1.56M | 1.33M | 598.34K | 347.99K | 243.17K | 162.52K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 109 | 388 | 44.51K | 53.94K | 53.87K | 27.54K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.46M | 10.8M | 10.89M | 7.66M | 6.72M | 4.68M | 4.99M | 7.39M | 4.7M | 5.59M | 5.38M | 4.52M | 3.72M | 2.52M | 3.79M | 1.53M | 1.56M | 1.33M | 598.34K | 347.99K | 243.17K | 162.52K |
Income Tax Expense | 14.32K | n/a | 11.27K | 7.72K | 8.91K | 9.82K | 10.79K | 11.14K | 10.27K | 8.84K | 8.09K | 6.81K | 6.35K | 5.17K | 5.26K | 1.67K | 1.72K | 1.62K | 1.48K | 1.34K | 1.61K | 1.59K |
Shares Outstanding (Basic) | 63.77M | 55.37M | 38.29M | 31.93M | 29.98M | 29.7M | 27.54M | 29.42M | 28.79M | 23.44M | 19.92M | 18.58M | 15.04M | 13.9M | 13.23M | 13.92M | 13.88M | 13.83M | 7.58M | 7.2M | 8.77M | 8.77M |
Shares Outstanding (Diluted) | 63.77M | 55.37M | 38.29M | 31.93M | 29.98M | 29.7M | 27.54M | 29.42M | 28.79M | 23.44M | 19.92M | 18.58M | 15.04M | 13.9M | 13.23M | 13.92M | 13.88M | 13.83M | 7.58M | 7.2M | 8.77M | 8.77M |
EPS (Basic) | -0.18 | -0.18 | -0.28 | -0.24 | -0.22 | -0.15 | -0.17 | -0.24 | -0.15 | -0.22 | -0.26 | -0.23 | -0.24 | -0.18 | -0.29 | -0.11 | -0.11 | -0.10 | -3 | -0.06 | -0.02 | -0.12 |
EPS (Diluted) | -0.18 | -0.18 | -0.28 | -0.24 | -0.22 | -0.15 | -0.17 | -0.24 | -0.15 | -0.22 | -0.26 | -0.23 | -0.24 | -0.18 | -0.29 | -0.11 | -0.11 | -0.10 | -3 | -0.06 | -0.02 | -0.12 |
EBITDA | -11.54M | -10.67M | -10.59M | -7.48M | -6.53M | -4.47M | -4.76M | -7.11M | -4.37M | -5.3M | -5.14M | -4.34M | -3.59M | -2.49M | -3.79M | -1.53M | -1.56M | -1.33M | -22.71M | -347.37K | -152.55K | -986.91K |
EBIT | -11.54M | -10.8M | -10.68M | -7.58M | -6.61M | -4.53M | -4.8M | -7.14M | -4.4M | -5.32M | -5.15M | -4.34M | -3.59M | -2.49M | -3.79M | -1.53M | -1.56M | -1.33M | -22.71M | -347.99K | -153.17K | -987.52K |
Depreciation & Amortization | n/a | 130.77K | 90.63K | 96.99K | 79.84K | 59.18K | 41.34K | 25.91K | 24.3K | 23.85K | 3.08K | 1.38K | 506 | 505 | 566 | 566 | 383 | 620 | 620 | 620 | 620 | 608 |
Add to Watchlist
Select watchlists to add or remove IMMX